Anti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R POMES

Clinical trial NCT03879382 · UNKNOWN

Trial details

NCT number: NCT03879382
Sponsor: Hrain Biotechnology Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

POMES Syndrome Relapsed and Refractory POMES Syndrome

Start date: 2019-02-27
Primary completion: 2020-08-30
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.